Crinetics Pharmaceuticals Stock Price. Everything You Need To Know About The Crinetics Pharmaceuticals Stock!
Crinetics Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. The company is headquartered in San Diego, California and currently employs 210 full-time employees. The company went IPO on 2018-07-18. The firm is focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. The company has discovered a pipeline of oral nonpeptide (small molecule) new chemical entities that target peptide GPCRs to treat a variety of rare endocrine diseases. The Company’s product candidates include paltusotine, CRN04777 and CRN04894. Its paltusotine is in clinical development for the treatment of acromegaly and neuroendocrine tumors. CRN04894 is an investigational, oral, nonpeptide product candidate designed to antagonize the ACTH receptor, intended for the treatment of diseases caused by excess adrenocorticotrophic hormone (ACTH), including Cushing’s disease and congenital adrenal hyperplasia (CAH). CRN04777 is an investigational, oral, nonpeptide somatostatin receptor type 5, agonist designed for the treatment of congenital hyperinsulinism (HI).
Crinetics Pharmaceuticals Stock Price. Everything You Need To Know About The Crinetics Pharmaceuticals Stock! performance
- Employees 210
- Company HQ San Diego
- Website https://www.crinetics.com/
- CRNX Asset Type Common Stock
- CRNX Market Capitalization 3.3B
- Earnings Per Share -3.69
- Dividends Per Share None
- Dividend Date None
- Quarterly Earnings Growth 0
Are you a retail investor from Malaysia, Thailand, Indonesia, or Vietnam looking to invest in the stock market? Look no further than Crinetics Pharmaceuticals. As a content marketing expert at Zorion, an investment platform that offers real US stocks and Pre-IPO companies, I can guide you on how to invest in Crinetics Pharmaceuticals from your respective countries. Crinetics Pharmaceuticals is a biopharmaceutical company focused on developing novel therapeutics for serious endocrine diseases. With our investment insights and recommendations, you can make informed decisions about your investments. Plus, our resources and educational materials will further enhance your investment knowledge. Start investing in Crinetics Pharmaceuticals and unlock your financial potential.
